Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Atkins

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
JAMA|November 1, 1995
Reporting randomized controlled trialsC D Atkins
The New England Journal of Medicine|December 12, 1996
High-dose chemotherapy in multiple myelomaC D Atkins
The New England Journal of Medicine|January 5, 1999
Clodronate in metastatic breast cancerC D Atkins
Journal of the National Cancer Institute|September 7, 1994
Re: Validation of the Gail et al. model for predicting individual breast cancer riskC D Atkins
Lancet (London, England)|February 24, 2001
Tamoxifen and risk of endometrial cancerC D Atkins
Lancet (London, England)|May 9, 2000
Long-term outcome of invasive breast cancerC D Atkins
The New England Journal of Medicine|October 27, 1994
Preventive health servicesC D Atkins
JAMA|February 22, 1995
Estrogen replacement therapy in breast cancer survivorsC D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Effect of flutamide withdrawal on response assessment of estramustine and etoposide for prostate cancerC D Atkins
The New England Journal of Medicine|August 11, 1994
Interferon alfa-2a for chronic myeloid leukemiaC D Atkins
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
JAMA|November 1, 1995
Reporting randomized controlled trialsC D Atkins
The New England Journal of Medicine|December 12, 1996
High-dose chemotherapy in multiple myelomaC D Atkins
The New England Journal of Medicine|January 5, 1999
Clodronate in metastatic breast cancerC D Atkins
Journal of the National Cancer Institute|September 7, 1994
Re: Validation of the Gail et al. model for predicting individual breast cancer riskC D Atkins
Lancet (London, England)|February 24, 2001
Tamoxifen and risk of endometrial cancerC D Atkins
Lancet (London, England)|May 9, 2000
Long-term outcome of invasive breast cancerC D Atkins
The New England Journal of Medicine|October 27, 1994
Preventive health servicesC D Atkins
JAMA|February 22, 1995
Estrogen replacement therapy in breast cancer survivorsC D Atkins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Effect of flutamide withdrawal on response assessment of estramustine and etoposide for prostate cancerC D Atkins
The New England Journal of Medicine|August 11, 1994
Interferon alfa-2a for chronic myeloid leukemiaC D Atkins
Pageof 5